Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Christians

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Transplantation|April 30, 1999
Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatmentB Hausen, K Boeke, G J Berry, et al.
British Journal of Pharmacology|April 1, 1996
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamberA Lampen, U Christians, A K Gonschior, et al.
Bone Marrow Transplantation|July 1, 1993
Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMTU Christians, K Spiekermann, A Bader, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycinU Christians, M Sattler, H M Schiebel, et al.
Therapeutic Drug Monitoring|October 1, 1995
Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipientsU Christians, K Kohlhaw, T Sürig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1991
Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomesU Christians, S Strohmeyer, R Kownatzki, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 1999
The histology of subcutaneously implanted donor bronchial rings correlates with rejection scores of lung allografts in a primate lung transplant modelB Hausen, G J Berry, P Dagum, et al.
British Journal of Pharmacology|March 11, 2000
The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphatesN Serkova, L Litt, D Leibfritz, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycinI Segarra, T R Brazelton, N Guterman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatinW Jacobsen, B Kuhn, A Soldner, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Transplantation|April 30, 1999
Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatmentB Hausen, K Boeke, G J Berry, et al.
British Journal of Pharmacology|April 1, 1996
Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamberA Lampen, U Christians, A K Gonschior, et al.
Bone Marrow Transplantation|July 1, 1993
Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMTU Christians, K Spiekermann, A Bader, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1992
Isolation of two immunosuppressive metabolites after in vitro metabolism of rapamycinU Christians, M Sattler, H M Schiebel, et al.
Therapeutic Drug Monitoring|October 1, 1995
Parallel blood concentrations of second-generation cyclosporine metabolites and bilirubin in liver graft recipientsU Christians, K Kohlhaw, T Sürig, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 1, 1991
Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomesU Christians, S Strohmeyer, R Kownatzki, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 1999
The histology of subcutaneously implanted donor bronchial rings correlates with rejection scores of lung allografts in a primate lung transplant modelB Hausen, G J Berry, P Dagum, et al.
British Journal of Pharmacology|March 11, 2000
The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphatesN Serkova, L Litt, D Leibfritz, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycinI Segarra, T R Brazelton, N Guterman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2000
Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatinW Jacobsen, B Kuhn, A Soldner, et al.
Pageof 9